Purinylalkyl benzamide derivatives

Details Purinylalkyl benzamide derivatives Purinylalkyl benzamide derivatives

1996-10-02

1999-01-19

Berch, Mark L.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

514262, 514263, 544264, 544265, 544271, 544276, 544277, A61K 3152, C07D47340, C07D47300, C07D47330

Patent

active

058614036

ABSTRACT:
The present invention relates to compounds of the formula ##STR1## wherein HET is ##STR2## m is an integer from 1 to 4; R.sup.1 and R.sup.2 are independently selected from the group consisting of linear or branched alkyl of 1 to 6 carbon atoms; and cycloalkyl or cycloalkylalkyl having 3 to 7 ring carbon atoms, the ring carbon atoms optionally substituted with one or more alkyl groups having 1 to about 4 carbon atoms each;

REFERENCES:
Strickland, Bioworld Today, p. 1.
Guinot, J. Lipid Mediators Cell Signalling 10, 141-146, 1994.
Tang, Drug Devel. Res. 29, 216, 1993.
Fink, Abstract of J. Antimicrobial Chemotherapy 41/Suppl. A, 81-94, 1988.

Affiliated with

Also associated with

Rating

Purinylalkyl benzamide derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Purinylalkyl benzamide derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Purinylalkyl benzamide derivatives will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1246861